Zynex, Inc. (ZYXI)
-OTC Markets 0.47 
0.00(0.02%) Jun 17, 2:45PM EDT
| Prev Close: | 0.47 |
|---|
| Open: | 0.42 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 0.50 |
|---|
| Beta: | 0.77 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | 0.42 - 0.47 |
|---|
| 52wk Range: | 0.35 - 1.01 |
|---|
| Volume: | 6,780 |
|---|
| Avg Vol (3m): | 11,977 |
|---|
| Market Cap: | 14.64M |
|---|
| P/E (ttm): | 15.66 |
|---|
| EPS (ttm): | 0.03 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- ZYNEX INC FinancialsEDGAR Online Financials(Fri, May 17)
- ZYNEX INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, May 13)
- ZYXI Q1: Revenue and Margins ImpactedZacks Small Cap Research(Thu, May 9)
- Zynex Announces First Quarter 2013 Financial ResultsMarketwired(Wed, May 8)
- Q1 2013 Zynex Inc Earnings Release - Before Market OpenCCBN(Wed, May 8)
- ZYNEX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Wed, May 8)
- Zynex Schedules First Quarter 2013 Earnings Release and WebcastMarketwired(Wed, May 1)
- Kevin M. Smith Appointed to Zynex Board of DirectorsMarketwired(Tue, Apr 30)
- ZYNEX INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Thu, Apr 25)
- Form 10 K for Zynex Inc.WILink(Wed, Apr 3)
- ZYNEX INC Files SEC form 10-K, Annual ReportEDGAR Online(Thu, Mar 28)
- Zynex Signs Strategic Agreement With Neurovirtual, Enters EEG and Sleep Diagnostic MarketMarketwired(Mon, Mar 18)
- ZYXI Revenue Growth ContinuesZacks(Thu, Mar 14)
- ZYXI Revenue Growth ContinuesZacks Small Cap Research(Thu, Mar 14)
- ZYNEX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Thu, Mar 14)
Key Statistics
| Forward P/E (1 yr): | 11.75 |
|---|
| P/S (ttm): | 0.38 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.02 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.01 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Zynex, Inc. engages in the design, development, manufacture, and distribution of medical devices. The company offers electrotherapy medical devices, such as IF 8000, an interferential current (IF) and neuromuscular electrical stimulation (NMES) de...
View More